UTHSC sickle cell researcher on ground floor in latest FDA approvals
For years sickle cell has been treated simply with pain medicine, but new research breakthroughs are producing therapies that can really attack the disease and improve lives.
Topics
Kenneth Ataga sickle cell UTHSCJane Roberts
Jane Roberts has reported in Memphis for more than 20 years. As a senior member of The Daily Memphian staff, she was assigned to the medical beat during the COVID-19 pandemic. She also has done in-depth work on other medical issues facing our community, including shortages of specialists in local hospitals. She covered K-12 education here for years and later the region’s transportation sector, including Memphis International Airport and FedEx Corp.
Want to comment on our stories or respond to others? Join the conversation by subscribing now. Only paid subscribers can add their thoughts or upvote/downvote comments. Our commenting policy can be viewed here.